Why the study?
Do angiotensin-converting enzyme inhibitors improve survival and reduce cardiovascular events in patients following acute myocardial infarction?
Population
Patients following acute myocardial infarction, including those with asymptomatic left ventricular…
Design
Review
Authors
Loading...
Supports targeted post-MI ACE inhibitor use in LV dysfunction or heart failure; leaves open broad efficacy in unselected patients.
Do angiotensin-converting enzyme inhibitors improve survival and reduce cardiovascular events in patients following acute myocardial infarction?
This review highlights that ACE inhibitors improve survival and prevent heart failure in post-myocardial infarction patients, particularly those with left ventricular dysfunction or clinical heart failure.
Robert J. Cody (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: